These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2481436)

  • 21. An acidic lymphokine distinct from interferon-gamma inhibits the replication of herpes simplex virus in human pulmonary macrophages.
    Rose RM; Wasserman AS; Weiser WY; Remold HG
    Cell Immunol; 1986 Feb; 97(2):397-406. PubMed ID: 3017578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. C1 dissociation. Spontaneous generation in human serum of a trimer complex containing C1 inactivator, activated C1r, and zymogen C1s.
    Laurell AB; Mårtensson U; Sjöholm AG
    J Immunol; 1987 Dec; 139(12):4145-51. PubMed ID: 2826582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of a lymphokine produced by human T cells which inhibits collagen synthesis.
    Rosenbloom J; McArthur W; Malamud D; Jimenez S
    Cell Immunol; 1983 Oct; 81(1):192-8. PubMed ID: 6604586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reversible defect in antigen-induced lymphokine and gamma-interferon generation in cutaneous leishmaniasis.
    Murray HW; Rubin BY; Carriero S; Acosta AM
    J Immunol; 1984 Oct; 133(4):2250-4. PubMed ID: 6432909
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of human monocyte cytotoxicity by natural and recombinant immune interferon.
    Le J; Prensky W; Yip YK; Chang Z; Hoffman T; Stevenson HC; Balazs I; Sadlik JR; Vilcek J
    J Immunol; 1983 Dec; 131(6):2821-6. PubMed ID: 6417232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Further studies on the identification of the subcomponents of the first component of complement after affinity chromatography of human serum on IgG-sepharose.
    Taylor PA; Fink S; Bing DH; Painter RH
    J Immunol; 1977 May; 118(5):1722-7. PubMed ID: 858917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interferons as macrophage-activating factors. III. Preferential effects of interferon-gamma on the interleukin 1 secretory potential of fresh or aged human monocytes.
    Arenzana-Seisdedos F; Virelizier JL; Fiers W
    J Immunol; 1985 Apr; 134(4):2444-8. PubMed ID: 3919095
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gold inhibition of the production of the second complement component by lymphokine-stimulated human monocytes.
    Littman BH; Schwartz P
    Arthritis Rheum; 1982 Mar; 25(3):288-96. PubMed ID: 6802142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Purification and characterization of cytostatic lymphokines produced by activated human T lymphocytes. Synergistic antiproliferative activity of transforming growth factor beta 1, interferon-gamma, and oncostatin M for human melanoma cells.
    Brown TJ; Lioubin MN; Marquardt H
    J Immunol; 1987 Nov; 139(9):2977-83. PubMed ID: 3117884
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Purification and characterization of histidine decarboxylase from mouse kidney.
    Martin SA; Bishop JO
    Biochem J; 1986 Mar; 234(2):349-54. PubMed ID: 3718471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Production of the second component of complement by human monocytes: stimulation by antigen-activated lymphocytes or lymphokines.
    Littman BH; Ruddy S
    J Exp Med; 1977 May; 145(5):1344-52. PubMed ID: 858999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibody-independent activation of C1. II. Evidence for two classes of nonimmune activators of the classical pathway of complement.
    Peitsch MC; Kovacsovics TJ; Tschopp J; Isliker H
    J Immunol; 1987 Mar; 138(6):1871-6. PubMed ID: 3029223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Partial purification and characterization of a human lymphokine which induces antileishmanial activity in mouse macrophages.
    Buchmuller Y; Weiser WY; Remold HG
    Cell Immunol; 1985 Jan; 90(1):242-50. PubMed ID: 3881189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Purification of a suppressor lymphokine (SL) from a human T-cell line.
    Abolhassani M; Muraki J; Chiao JW
    Immunol Invest; 1989 Jul; 18(6):741-51. PubMed ID: 2767735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification and characterization of a human T cell line-derived lymphokine with MAF-like activity distinct from interferon-gamma.
    Lee JC; Rebar L; Young P; Ruscetti FW; Hanna N; Poste G
    J Immunol; 1986 Feb; 136(4):1322-8. PubMed ID: 3003193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biosynthesis of the first component of complement by human fibroblasts.
    Reid KB; Solomon E
    Biochem J; 1977 Dec; 167(3):647-60. PubMed ID: 603627
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The unactivated form of the first component of human complement, C1.
    Gigli I; Porter RR; Sim RB
    Biochem J; 1976 Sep; 157(3):541-8. PubMed ID: 985398
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Purification of cytostatic protein factors released from human monocytes.
    Nissen-Meyer J; Kildahl-Andersen O
    Scand J Immunol; 1984 Oct; 20(4):317-25. PubMed ID: 6505639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A lymphokine distinct from interferon-gamma that activates human monocytes to kill Leishmania donovani in vitro.
    Hoover DL; Finbloom DS; Crawford RM; Nacy CA; Gilbreath M; Meltzer MS
    J Immunol; 1986 Feb; 136(4):1329-33. PubMed ID: 3080522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Purification and partial sequence of human osteoclast-activating factor: identity with interleukin 1 beta.
    Dewhirst FE; Stashenko PP; Mole JE; Tsurumachi T
    J Immunol; 1985 Oct; 135(4):2562-8. PubMed ID: 3875658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.